| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107
Puromycin aminonucleoside arrests cultured normal human lung fibroblasts in the G1 and G2 phases of the cell cycle but permits fibroblasts transformed by the oncogenic virus SV40 to continue their cell-cycle traverse. Aminonucleoside has no detectable effect on the entry of the transformed cells into mitosis but it does accelerate the rate of detachment of these cells from the growth surface. These differences were not due to an altered rate of penetration of the membrane of the transformed cells by amino-nucleoside.
1 This work was supported by USPHS Research Grants CA12334-02 and CA12351-02 from the National Cancer Institute.
2 Present address: Medical Research Institute, Putnam Memorial Hospital, Bennington, Vt. 05201.
3 To whom reprint requests and correspondence should be addressed.
Received 4/13/73. Accepted 7/18/73.
This article has been cited by other articles:
![]() |
J. J. Cholon and G. P. Studzinski Metabolic Differences between Normal and Neoplastic Cells: Effects of Aminonucleoside on Cytoplasmic Messenger RNA Science, April 12, 1974; 184(4133): 160 - 161. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |